Latest News

July 25, 2025

The Summer 2025 advocacy blog, Considering Clinical Trials, is now available

July 15, 2025

Consolidation blinatumomab with chemotherapy improves survival in younger B-cell ALL patients aged 30-54 (study E1910)

July 15, 2025

CBS Sunday Morning highlights cancer research funding crisis in ‘Saving Money vs. Saving Lives’ segment

July 10, 2025

The July 2025 News from ECOG-ACRIN blog is now available

June 24, 2025

Press Release: Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel chemotherapy warrants further investigation in HR+ HER2- metastatic breast cancer

June 11, 2025

The June 2025 News from ECOG-ACRIN blog is now available

June 5, 2025

WATCH: Dr. Nadine Tung discusses CompassHER2-pCR (EA1181) breast cancer trial data at ASCO 2025

June 5, 2025

WATCH: Dr. Ahmad Tarhini discusses pembrolizumab and vidutolimod as a promising pre-surgery strategy for high-risk melanoma based on the EA6194 trial results presented at ASCO 2025

June 1, 2025

Press Release: Pre-operative THP leads to a pCR in two-thirds of early-stage HER2+ ER- breast cancer patients


About Us

The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1400 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More


Home

Scientific Pursuits

We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More


ECOG-ACRIN by the Numbers

Home
37

Active Clinical Trials

Home
1400

Participating Institutions

Home
67

International Sites

Home
21000

Individual Members


Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).

ECOG-ACRIN Cancer Research Group